A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

NCT07117175 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Immunology
Hematologic Malignancies
CAR-NK

Interventions

DRUG: Anti-human CD7 CAR-NK cell injection

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine